Amlodipine/bisoprolol - Merck KGaA
Alternative Names: Bisoprolol/amlodipine; Concor-AMLatest Information Update: 28 Sep 2020
At a glance
- Originator Merck KGaA
- Class Antihypertensives; Dihydropyridines; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Calcium channel antagonists; Cytochrome P-450 enzyme system inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Essential hypertension
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for phase-I development in Essential-hypertension(In volunteers) in China (PO, Tablet)
- 27 Jun 2019 Chemical structure information added
- 09 Sep 2017 Merck KGaA completes a phase I trial in Healthy volunteers in China (NCT03226275)